Back Pain Lower Back Clinical Trial
Official title:
Improvement in Pain, Function and Quality of Life With a Protocolized Exercise Program Compared With Non-steroidal Anti-inflammatory Analgesics in Patients With Subacute Low Back Pain in Medellín, Colombia, 2009-2010
Our clinical trial has the purpose to evaluate the effectiveness in reducing pain and improving function and quality of life during a 6-months follow-up of a therapeutic exercise program compared to pharmacological treatment with NSAIDs in patients with subacute low back pain attending the physiatrist consultation of several ambulatory health centers in Medellín during the years 2009-2010.
General Purpose To evaluate the effectiveness in reducing pain and improving function and
quality of life during a 6-months follow-up of a therapeutic exercise program compared to
pharmacological treatment with NSAIDs in patients with subacute low back pain attending the
physiatrist consultation of several ambulatory health centers in Medellín during the years
2009-2010.
Specific Objectives
1. To evaluate the efficacy of a protocolized exercise program in reducing low back pain.
2. To evaluate the efficacy of a protocolized exercise program in improving the function.
3. To compare the effects of both interventions on quality of life and work absenteeism in
the two groups of patients.
4. To compare the safety of both interventions.
5. To estimate adherence and causes of non-adherence of patients to different treatments
proposed.
6. To compare in both groups the number of relapses, general and specialized medical
consultations, screening studies, images and other treatments associated with low back
pain.
Null Hypothesis Management of subacute low back pain patients with a protocolized
exercise program is not more effective than treatment with NSAIDs to reduce pain at
least in 25 mm, measured with a Visual Analog Scale 0-100 mm.
Alternative hypothesis Management of subacute low back pain patients with a
protocolized exercise program is not more effective than treatment with NSAIDs to
reduce pain at least in 25 mm, measured with a Visual Analog Scale 0-100 mm.
Methodology:
Type of study: randomized controlled clinical trial, single-blinded with independent
evaluators.
Reference population: Patients consulting physiatrists in different physical medicine
and rehabilitation departments in Medellin, Colombia.
Study population: patients with subacute low back pain -evolution time more than 6
weeks and less than 3 months-, with or without radiculopathy, and that fulfill
inclusion criteria. In addition patients must sign an informed consent to participate
in research.
Inclusion criteria:
- Patients aged between 18 and 60 years with subacute low back pain.
- Evolution time more than 6 weeks and less than 3 months.
- That were included in the social security system and live in the metropolitan
area.
Exclusion criteria:
- Antecedents of spinal, pelvis or abdominal trauma.
- Cancer.
- Diabetes mellitus.
- Steroid use.
- Women over 60 years.
- Cauda equine syndrome.
- Men with osteoporosis or compression fractures.
- Suspicion of infection
- Insidious onset
- Constitutional symptoms
- Intravenous drugs abuse
- HIV
- Immunosuppression
- Previous surgery
- Rheumatic diseases
- Urinary tract infections
- Neurological symptoms in lower limbs
- Mental illness (schizophrenia, bipolar or somatomorphic disorder, major
depression)
- Deformities in the spine (scoliosis greater than 15º)
- History of peptic acid disease
- Renal failure
- Intake of anticoagulants or antiplatelet drugs
- Allergy to NSAIDs.
Primary outcome Pain relief more than 25 mm on the Visual Analogue Scale, ranging from
0 to 100, assessed 4 weeks after intervention.
Secondary outcomes:
Improvement in function assessed by the Oswestry Disability Index and Roland-Morris
questionnaire comparing baseline to first, three and six months follow-up.
Improvement in quality of life assessed by SF-36 (The Short Form Health Survey)
questionnaire at baseline and at first, third and sixth months.
Work absenteeism decrease. Decrease in the number of relapses, general and specialized
medical consultations, screening studies, images and other treatments associated with
low back pain at 6 months.
Safety of both treatments evaluated in the exercise group by tolerance to training and
presence or not of side effects, and in the NSAIDs group by the presence or absence of
adverse reactions.
Sample:
Sampling type: simple random. Sample size calculation was based on software "Sample
size Javeriana University" Type I error: 0.05 Type II Error: 0.2 Assessments number
prior to randomization: 1 Assessments number after randomization: 3 Correlation between
evaluations: 0.8 Clinically important difference: 0.33 Number of patients per group: 33
Experimental group control group ratio : 1 to 1 10% of loss: 7 Total: 73
Randomization Randomization was done by means of permuted blocks of size 2, 4 and 6,
generated by computer (Ralloc program, co Stata 8.2, College Station, TX, USA).
Allocation will be confidential and will not be opened until the investigation is
completed, this will be monitored by the Committee of Data Security.
Enrollment Patients with subacute low back pain consulting Physical Medicine and
Rehabilitation Departments of hospitals in Medellín, Colombia. There will be an initial
assessment, and if patient is considered eligible will be invited to participate and
asked to sign an informed consent (Appendix 1). Treatment assignment will be given in
an opaque envelope.
Masking Medical researchers who evaluate the patients, research assistants who perform
the application of different measure instruments and statistical will be blinded to
treatment allocation.
Initial assessment Clinical evaluation will be performed by one of the research
physiatrists. Evaluation will include: epidemiological and clinical, Visual Analog
Scale (VAS), Oswestry scale, Rolland Morris Scale, and SF-36 quality of life scale.
Intervention One group will be assigned to protocolized back pain exercise, three times
a week for 4 weeks. This program is carried out by physiotherapists from participating
institutions who wish to participate in research and who will be given a training which
will standardize the intervention programs Exercise program includes: physical agents,
massage of myofascial points, stretching and strengthening exercises, cycloergometer or
band aerobic exercises. Treatment, type of exercises, exercise tolerance and adverse
reactions will be registered. The second group will receive NSAID for 10 days, there
will be two different options (naproxen or celecoxib) according to indications and
contraindications. In case of increase in pain intensity in either of the two groups,
acetaminophen in doses of 1.5 to 2.0 g / day will be used as a rescue.
Adherence to different treatments. To ensure adherence to different treatments each
patient will receive a phone call weekly to inquire about assistance, difficulties,
tolerance, use of medications, and adverse effects. Patients will be given a
questionnaire to verify drugs intake, dosage, time and side effects. They should also
register any other drug ingestion.
Telephone calls will be made every 15 days to ask about the health status and ensuring
assistance to new assessments.
Assessment will be scheduled at 1, 3, and 6 months Clinical evaluation will be
performed by one of the researcher physiatrists or a postgraduate student.
Committee of safety and quality of data. This committee will consist of two researchers
and one professional information management responsible for the database. This will be
done in Access and SPSS 15 (Statistical Product and Service Solutions) before starting
information recollection.
Analysis Plan Categorical univariate variables will be analyzed by frequency
distributions and quantitative variables by measures of central tendency (mean,
standard deviation, median or range). Both groups will be compared after randomization
and before intervention for all variables.
Initially, it will be established for each group if the quantitative variables are of
normal distribution, by using the Kolmogorov-Smirnov test.
Pain (primary outcome) will be evaluated in each patient at 1, 3 and 6 months and will
be compared with initial pain (mean and confidence intervals) by using Student t test
or Mann Whitney for each time period. The same procedure would be for the other
outcomes measured quantitatively.
An analysis of variance with repeated measures for the variability between groups and
intragroup will be made.
Comparison of categorical variables at each assessment will be done using the Chi2
test.
The level of statistical significance to be used in all cases is 0.05. An analysis by
intention to treat and per protocol will be made.
Ethics This research and informed consent is according to "Scientific, technical and
administrative standards for health research" of the Ministry of Health and the Decree
309 of 2000 of the Ministry of Environment. This is considered a minimal risk research,
because therapeutic interventions are widely used to treat patients with these
conditions.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00741650 -
Ibedrift- A Trial Comparing a New Approach to Musculoskeletal Pain Consisting of Education and Peer Involvement to Treatment as Usual
|
Phase 2/Phase 3 |